Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2022-08-05 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Regulatory Filings Classification · 95% confidence The document is a notice from the company to the stock exchange about the scheduling of a Board Meeting to consider and approve unaudited financial results for the quarter ended June 30, 2022. It also announces the closure of the trading window in compliance with insider trading regulations. The document does not contain any financial data or results itself, nor does it present a report. It is an announcement regarding an upcoming board meeting and trading restrictions. The document length is short (2173 characters) and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2022-08-05 English
Fermenta Biotech Limited - Publication of Notice to equity shareholders Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing ....
Regulatory Filings
2022-08-02 English
Publication of 'Notice of the Meetings of Equity Shareholders and Secured and Unsecured Creditors of Fermenta Biotech Limited'
Regulatory Filings
2022-08-02 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform that the Notice of NCLT convened Meeting of Secured Creditors ....
Merger & Acquisition Classification · 100% confidence The document is a detailed notice convening a meeting of secured creditors of Fermenta Biotech Limited pursuant to an order by the National Company Law Tribunal (NCLT). It relates to the approval of a Composite Scheme of Amalgamation and Arrangement under sections 230 to 232 of the Companies Act, 2013. The document includes an index of annexures such as the scheme itself, valuation reports, fairness opinions, no objection certificates, board reports, audited financial statements, proxy forms, and attendance slips. The primary purpose is to inform and seek approval from secured creditors for the merger/amalgamation scheme. This is a formal meeting notice and related explanatory materials for a creditor meeting convened by a tribunal order, which is typical for merger and acquisition related filings. It is not an annual report, earnings release, or regulatory filing unrelated to M&A. The presence of the scheme, valuation, fairness opinion, and NCLT order references clearly indicate this is an M&A activity filing. Therefore, the correct classification is Merger & Acquisition (MA). The document length and detail confirm it is the actual meeting notice and related materials, not just an announcement or proxy solicitation alone.
2022-08-01 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform that the Notice of NCLT convened Meeting of Unsecured Creditors ....
Regulatory Filings
2022-08-01 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform that the Notice of NCLT convened Meeting of Equity Shareholders ....
Regulatory Filings
2022-08-01 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.